Production (Stage)
Camp4 Therapeutics Corporation
CAMP
$2.00
-$0.005-0.25%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -- | -49.65M | -49.44M |
| Total Depreciation and Amortization | -- | -- | -- | 1.73M | 1.71M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | 4.76M | 4.75M |
| Change in Net Operating Assets | -- | -- | -- | 1.39M | 589.50K |
| Cash from Operations | -- | -- | -- | -41.77M | -42.39M |
| Capital Expenditure | -- | -- | -- | -554.00K | -579.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -554.00K | -579.00K |
| Total Debt Issued | -- | -- | -- | 0.00 | 353.00K |
| Total Debt Repaid | -- | -- | -- | -848.00K | -719.00K |
| Issuance of Common Stock | -- | -- | -- | 177.00K | 181.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -304.00K | -- |
| Cash from Financing | -- | -- | -- | -975.00K | -184.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | -43.30M | -43.15M |